Influence of CYP2C9 Genetic Polymorphism and Undernourishment on Plasma-Free Phenytoin Concentrations in Epileptic Patients
- 1 December 2010
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Therapeutic Drug Monitoring
- Vol. 32 (6), 762-766
- https://doi.org/10.1097/ftd.0b013e3181fa97cc
Abstract
The objective of this study was to study the effect of CYP2C9 genetic polymorphism and undernourishment on free phenytoin concentrations in epileptic patients. The study was done in 70 patients who were taking phenytoin therapy for the treatment of epileptic seizures. Genotyping of CYP2C9 (*2 and *3) was determined by the polymerase chain reaction-restriction fragment length polymorphism method. Bound and free plasma phenytoin was separated using equilibrium dialysis technique. Total and free phenytoin concentrations were measured by the reverse-phase high-performance liquid chromatography method. Patients were broadly classified into well-nourished and undernourished and further subclassified by CYP2C9 genotypes. In well-nourished groups (G1 to G3 group), free phenytoin concentrations were significantly higher in the heterozygous poor metabolizer of CYP2C9 genotype (G2) group (3.1 ± 0.62 μg/mL) and homozygous poor metabolizer of CYP2C9 genotype (G3) group (4.3 ± 1.76 μg/mL) when compared with patients with the wild-type CYP2C9 (G1) group (1.1 ± 0.72 μg/mL). Similarly, in undernourished patient groups (G4-G6 group), free phenytoin concentrations were significantly higher in the wild-type CYP2C9 (G4) group (2.5 ± 0.52 μg/mL), heterozygous poor metabolizer of CYP2C9 genotype (G5) group (4.3 ± 1.76 μg/mL), and homozygous poor metabolizer of CYP2C9 genotype (G6) group (8.2 ± 1.08 μg/mL) when compared with well-nourished patients with the wild-type CYP2C9 (G1) group (1.1 ± 0.72 μg/mL). The percentage increase in free phenytoin concentration by undernourishment, CYP2C9 allelic variants, and undernourishment cum CYP2C9 allelic variants were 127%, 290%, and 472%, respectively, compared with well-nourished patients with the wild-type CYP2C9 genotype (G1) group. The contribution of undernourishment and genetic factors (CYP2C9 allelic variant) for developing phenytoin toxicity was calculated to have an odds ratio of 37.3 (P < 0.0001). Undernourishment and variant CYP2C9 alleles elevate free phenytoin concentrations individually and in combination show additive effects.Keywords
This publication has 30 references indexed in Scilit:
- Differences between the Measured and Calculated Free Serum Phenytoin Concentrations in Epileptic PatientsYonsei Medical Journal, 2009
- Pharmacokinetic changes in drugs during protein-calorie malnutrition: correlation between drug metabolism and hepatic microsomal cytochrome p450 isozymesArchives of Pharmacal Research, 2004
- Synergistic Effect of Valproate Coadministration and Hypoalbuminemia on the Serum-Free Phenytoin Concentration in Patients With Severe Motor and Intellectual DisabilitiesClinical Neuropharmacology, 2002
- Suppression of Rat Hepatic Cytochrome P450s by Protein-Calorie Malnutrition: Complete or Partial Restoration by Cysteine or Methionine SupplementationArchives of Biochemistry and Biophysics, 1999
- Effect of protein-calorie malnutrition on cytochromes P450 and glutathione S-transferaseEuropean Journal of Drug Metabolism and Pharmacokinetics, 1999
- Effects of protein malnutrition on liver cytochrome p450sNutrition Research, 1997
- Effect of CYP2C Polymorphisms on the Pharmacokinetics of Phenytoin in Japanese Patients with Epilepsy.Biological & Pharmaceutical Bulletin, 1996
- Phenytoin Toxicity Associated With Hypoalbuminemia in Critically Ill PatientsSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 1994
- Severe Phenytoin Intoxication as a Result of Altered Protein Binding in AidsDICP, 1990
- Should we routinely measure free plasma phenytoin concentration?British Journal of Clinical Pharmacology, 1984